Document |
Document Title |
WO/2016/063709A1 |
The present invention provides a method by which, at a stage prior to storing felled palm trunks, palm trunks in which the sugar concentration could increase can be efficiently selected and, as a result of storing the selected palm trunk...
|
WO/2016/065217A1 |
Multi-stage, biological processes and systems for converting a C1 carbon source to desired end products are described. The processes comprise dividing a gaseous C1-containing substrate, in parallel, among multiple bioreactor stages. Liqu...
|
WO/2016/062836A1 |
The invention relates to a capsule comprising: an inner phase comprising at least one plant cell, and an outer gel phase that encapsulates the entire inner phase on the periphery thereof, said outer phase comprising at least one surfacta...
|
WO/2016/059541A1 |
Provided herein are methods of culturing a microorganism. The method includes providing a container comprising one or more microorganisms and medium, wherein the microorganisms and medium form a start volume. The microorganisms and mediu...
|
WO/2016/059540A1 |
Provided herein are methods of culturing a microorganism. The methods include providing a container comprising one or more microorganisms in a medium, which has a first carbon to nitrogen ratio; culturing the microorganisms until the cul...
|
WO/2016/056944A1 |
The invention relates to the microbiological industry, microbiology and biotechnology, and specifically to the production of physiologically active compounds, and concerns the production of a protein, bacteriorhodopsin, by means of mi...
|
WO/2016/053003A1 |
The present invention relates to a method for preparing an aglycone converted from a glycoside and, specifically, to a method for preparing an aglycone from a glycoside by converting a glycoside into an aglycone form by using a microorga...
|
WO/2016/053648A1 |
A method for treating a low value carbon source to produce biologically labile carbon, comprising the steps of oxidizing the low value carbon source with at least one oxidizing agent to produce a modified, partially solubilized low value...
|
WO/2016/053131A1 |
The invention relates to the microbiology industry, microbiology and biotechnology, and specifically to the production of physiologically-active compounds, and concerns the production of the protein bacteriorhodopsin by means of micro...
|
WO/2016/045569A1 |
Processes for producing ethanol comprise saccharifying cellulosic material with a cellulolytic enzyme composition and fermenting the saccharified cellulosic material with a fermenting microorganism to produce ethanol. The fermenting orga...
|
WO/2016/044606A1 |
The present invention provides fermentation methods. Benzoates have been found to improve ethanol yield and decrease glycerol production in fermentation reactions using granular starch as the feedstock.
|
WO/2016/036748A1 |
A method for synthesizing cis, cis-muconic acid from a low value carbon source, comprising the steps of oxidizing the low value carbon source with at least one oxidizing agent to produce a modified, partially solubilized low value carbon...
|
WO/2016/033680A1 |
Provided are an apparatus and method for reducing the phenol concentration in a commercial enzyme solution and/or feedstock.
|
WO/2016/028188A1 |
A Halobacterium salinarum bacterial strain RNCIM [Russian National Collection of Industrial Microorganisms] В-11850 - a bacteriorhodopsin producer which exceeds the productivity of RNCIM B-10425 (in biomass and bacteriorhodopsin) is pro...
|
WO/2016/017572A1 |
The objective of the present invention is to reduce the quantity of carbon dioxide emitted when producing organic substances. This apparatus 1 for producing organic substances comprises a synthesis gas generation furnace 11 and a ferme...
|
WO/2016/017795A1 |
The purpose of the present invention is to provide: a method for evaluating the quality of a human mesenchymal stem cell; a method for separating, selecting and culturing a human mesenchymal stem cell; a human mesenchymal stem cell popul...
|
WO/2016/011554A1 |
The present disclosure provides a process for forming a biogenic carbon-based fuel or a fuel intermediate from biogenic carbon dioxide and hydrogen. The hydrogen is sourced from a process that produces hydrogen and fossil carbon dioxide ...
|
WO/2016/011555A1 |
A process is provided for forming a fuel or a fuel intermediate from two fermentations that includes feeding an aqueous solution comprising a fermentation product from a first bioreactor to a second bioreactor and/or a stage upstream of ...
|
WO/2016/007216A1 |
Processes, as well as associated systems and computer program (software) products, are disclosed for the biological conversion of CO into desired end products such as ethanol. The control methodologies used for these processes can advant...
|
WO/2016/004334A1 |
The invention provides a non-naturally occurring microbial organism having a butadiene, crotyl alcohol, 2,4-pentadienoate, 3-buten-2-ol, or 3-buten-1-ol, pathway. The microbial organism contains at least one exogenous nucleic acid encodi...
|
WO/2016/001203A1 |
The present invention concerns a recombinant strain belonging to the order of Actinomycetales, wherein at least one gene encoding an enzyme having vanillin reductase activity is non-functional. The present invention is also related to a ...
|
WO/2015/200287A1 |
Methods and systems for producing a particular biofuel or a particular chemical using genetically modified iron-oxidizing bacteria (IOB) and copper as a redox mediator are disclosed. In some embodiments, the methods include the following...
|
WO/2015/182110A1 |
The productivity of biomass within the cells of algae can be improved by suppressing the expression of ATG8 in algae by (i) overexpression of MEX1 and/or (ii) silencing using miRNA, thereby providing algae having improved productivity of...
|
WO/2015/182719A1 |
Provided are: a modified host cell formed by introducing into a micro-organism host cell a polynucleotide that codes tRNA having a high usage frequency relative to the amount supplied; a method for manufacturing said modified host cell; ...
|
WO/2015/170985A1 |
The present invention is in the field of fermentation, and pertains to a method for preparing yogurt by fermentation, comprising the steps of providing a fermentation starter culture comprising a selected microorganism in a suitable cult...
|
WO/2015/172119A1 |
The present invention relates to a method for optimizing production of eicosapentaenoic acid (EPA) production by cloning genes into a bacterial host, most preferably a modified Escherichia coli strain. Four polyunsaturated fatty acid (PU...
|
WO/2015/162283A1 |
Recombinant microorganisms and methods for producing saffron compounds including hydroxy-β-cylcocitral and picrocrocin are disclosed herein. Methods involve expression of a gene encoding a cytochrome p450 polypeptide, and optionally a g...
|
WO/2015/163694A1 |
The present invention relates to a method for preparing a garlic-fermented composition and a garlic-fermented composition prepared by the method, and the purpose of the present invention is to provide a garlic-fermented composition which...
|
WO/2015/158061A1 |
The present application provides a method for simultaneously synthesizing biological flocculants with polysaccharide and γ-PGA as active components by using bacillus licheniformis. The method comprises: transferring bacillus licheniform...
|
WO/2015/157194A1 |
A fluid filter formed of microbially-produced cellulose, preferably formed into a web of cellulose fibers in artificial culture of the microbes, then removed from the culture and shaped into a filter. The shaping may include a compressio...
|
WO/2015/141791A1 |
Provided is a method for producing an aniline derivative by fermentation from a carbon source such as glucose. A method for producing an aniline derivative, the method including the following steps: production of microorganisms capable o...
|
WO/2015/140700A1 |
The invention discloses a cell culture process comprising culturing cells in the presence of betaine to obtain a glycoprotein with a glycoform composition comprising increased percentage of afucosylated glycans. Further, the invention 5 ...
|
WO/2015/139141A1 |
Provided herein is a process for producing an alcohol from a sugar cane derived cellulosic feedstock comprising: subjecting the sugar cane derived cellulosic feedstock comprising bagasse, leaves, tops, or any combination thereof, to sili...
|
WO/2015/135068A1 |
The present document describes a carbon allotrope-silica composite material comprising a silica microcapsule comprising a silica shell having a thickness of from about 50 nm to about 500 µm, and a plurality of pores, said shell forming ...
|
WO/2015/127553A1 |
Disclosed is the use of a fruit kernel for producing biofuel or an intermediate in the production thereof. The fruit kernel is generally obtained from an avocado or mango and is used as a dry powder. Also disclosed are methods for produc...
|
WO/2015/128892A1 |
Provided is a lactic acid-fermented bamboo liquid that is not bulky, can be easily utilized according to use, and has excellent usefulness. The lactic acid-fermented bamboo liquid (22) is an extract obtained by blending bamboo leaf and b...
|
WO/2015/121704A2 |
A device for detecting bacteria in a sample, comprising: a substrate having a surface; and a plurality of Fe(III)-bound or Fe(III)-binding siderophores specific to the bacteria and covalently attached to the surface; wherein the sideroph...
|
WO/2015/117019A1 |
Genetically engineered cells and methods are presented that allow for the production of various value products from CO2. Contemplated cells have a CBB cycle that is genetically modified such that two molecules of CO2 fixed in the CBB cyc...
|
WO/2015/114115A1 |
The present disclosure concerns a process for obtaining a variant yeast strain capable of producing less ethanol in an alcoholic fermentation process than its corresponding ancestral strain. The variant yeast strain is obtained by cultur...
|
WO/2015/115790A1 |
The present invention relates to: Bacillus amyloliquefaciens K2G strain which has excellent anti-nutritional factor removal activity, protease activity and antibacterial activity against pathogens and has reduced mucus production; a meth...
|
WO/2015/095941A1 |
The invention describes a method for treating poultry slaughter effluents using Haematococcus Pluvialis micro-algae for said treatment, the effluent serving as a culture medium for Haematococcus Pluvialis micro-algae and for inducing the...
|
WO/2015/089675A1 |
In a bioreactor, microorganisms are kept in a circulation loop in communication with the inside of a membrane. The outside the membrane communicates with a fluid substrate. One or more nutrients pass from the substrate through the membra...
|
WO/2015/092575A1 |
Provided are polynucleotides and polypeptides involved in the biosynthesis of pamamycin and pamamycin precursors as well as vectors and recombinant microorganisms comprising the polynucleotides and polypeptides. Also provided are methods...
|
WO/2015/094117A1 |
There is provided an isolated codon optimised nucleic acid sequence that encodes a xylose isomerase protein or enzymatically active fragment thereof, comprising a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 1,...
|
WO/2015/088568A1 |
Processes are disclosed for bioconversion processes in which a ME biocatalyst is surrounded by water-insoluble liquid during the bioconversion to facilitate one or more of mass transfer of substrate to and bioproduct from the biocatalyst...
|
WO/2015/085012A1 |
Methods and systems are described for fermentative production and purification of bioproducts.
|
WO/2015/085003A1 |
Compositions and methods for minimizing antibody disulfide bond reduction are described. In one aspect, a composition is provided for culturing mammalian host cells to express an antibody including an anti-reduction agent that minimizes ...
|
WO/2015/067800A1 |
The present invention relates to fungal strains, which are a member of the genus Penicillium and have antifungal activity, and to cell-free extracts of said strains, culture media obtainable by culturing said strains and extrolites produ...
|
WO/2015/063240A1 |
Exopolysaccharide of a bacterial strain for its use in treatment and/or care of the skin, as well as its cosmetic and/or dermopharmaceutical compositions. In particular, its use for inflammation, lipolysis, lipid accumulation and skin fi...
|
WO/2015/063282A1 |
A method of producing a lactic acid bacteria (LAB) composition, or harvested LAB composition, with increased LAB viable active biomass using algae or a fraction thereof is described. The algae may be prokaryotic algae, such as a cyanobac...
|